September 8, 1994
James M. Sweeney, who engineered the March sale of McGaw Inc. to Ivax Corp., is taking his recently formed health-care company to Denver at the end of the month as it sheds 590 employees--or 21% of its 2,800-member work force--from facilities across the country. The layoffs at Coram Healthcare Corp., formed July 11 in a four-way merger Sweeney put together, are part of a broad restructuring that includes closing 83 facilities and taking a third-quarter pretax charge of $138.1 million.
September 9, 1994
* Charles A. Laverty has been hired as president and chief executive officer of Davstar Industries Ltd., a Costa Mesa manufacturer of disposable medical plastic products. Laverty takes over positions relinquished by Davstar's chairman, Jerry Silver, who will concentrate on new products and further growth through acquisitions. Laverty, 49, who was hired after a three-month search, comes with a reputation of being able to spur a company's growth, Silver said.
December 2, 1993 |
An Ontario, Calif.-based company that provides home infusion services will merge with two other companies to create one of the largest infusion concerns in the nation, the firms announced Wednesday. The stock-swap deal--the latest example of rapid consolidation in the health care industry--would combine Curaflex Health Services Inc. of Ontario, HealthInfusion Inc. of Miami and Medisys Inc. of Minneapolis.
August 5, 1994
* Patrick J. Fortune has been appointed president and chief operating officer of Coram Healthcare Corp. in Newport Beach, effective Aug. 15. He most recently served as corporate vice president of information management for Bristol-Meyers Squibb Co. Coram, which has announced plans to relocate its headquarters to Boulder, Colo., was formed as a result of the four-way merger last month of United T2 Medical, Curaflex Health Services, Medisys Inc. and HealthInfusion Inc.
September 27, 1994 |
In a settlement underscoring the government's commitment to regulate physicians' financial ties to private health-care providers, a unit of a Newport Beach home-infusion company has agreed to pay $500,000 to end a two-year investigation. The agreement between T2 Medical, an Atlanta company that supplies intravenous drugs and nutrients to patients in their homes, and the U.S. Department of Health and Human Services was filed Monday in U.S. District Court in Atlanta.